SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM

NCT05405166 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

531

Enrollment

INDUSTRY

Sponsor class

Conditions

Plasma Cell Myeloma Recurrent

Interventions

DRUG: Isatuximab IV
DRUG: Isatuximab SC
DRUG: Dexamethasone
DRUG: Pomalidomide
DRUG: Dexamethasone
DRUG: Montelukast
DRUG: Paracetamol / Acetaminophen
DRUG: Diphenhydramine
DRUG: Methylprednisolone

Sponsor

Sanofi